Xetra
13.02.26 | 17:35
37,530 Euro
+14,11 % +4,640
1-Jahres-Chart
5-Tage-Chart
| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 35,470 | 35,750 | 22:53 | |
| 35,265 | 35,680 | 22:01 |
► 13.02.: | | | | | | | | |
► 12.02.: | | | | | | | | |
► Aktueller MODERNA Börsenkurs + Xetra-Orderbuch
► 12.02.: | | | | | | | | |
► Aktueller MODERNA Börsenkurs + Xetra-Orderbuch
| Stück | Geld | Kurs | Brief | Stück |
|---|---|---|---|---|
| 460,40 | 40 | |||
| 170,00 | 8 | |||
| 150,00 | 57 | |||
| 60,00 | 15 | |||
| 51,76 | 50 | |||
| 46,800 | 1.030 | |||
| 45,000 | 401 | |||
| 44,000 | 300 | |||
| 42,000 | 300 | |||
| 35,760 | 235 | |||
Quelle: [URL] https://aktienkurs-orderbuch.finanznachrichten.de/0qf.htm [/URL] | ||||
| 235 | 35,345 | |||
| 500 | 31,000 | |||
| 100 | 30,000 | |||
| 120 | 20,800 | |||
| 300 | 20,000 | |||
| 1.052 | 0,000 | |||
| Summe Aktien im Kauf | Verhältnis | Summe Aktien im Verkauf | ||
| 2.307 | 1,056 | 2.436 | ||
| Uhrzeit | Aktienkurs | Stück |
|---|---|---|
| 17:35:46 | 37,530 | 407 |
| 17:30:22 | 37,350 | 10 |
| 17:29:46 | 37,255 | 582 |
| 17:29:25 | 37,020 | 72 |
| 17:28:25 | 37,120 | 11 |
| 17:28:25 | 37,120 | 6 |
| 17:27:22 | 36,965 | 17 |
| 17:27:17 | 36,995 | 125 |
| 17:25:14 | 36,905 | 45 |
| 17:25:14 | 36,905 | 30 |
| 17:25:14 | 36,905 | 15 |
| 17:22:15 | 36,770 | 25 |
| 17:22:10 | 36,850 | 42 |
| 17:18:50 | 37,185 | 247 |
| 17:17:43 | 37,215 | 337 |
| 17:14:55 | 37,330 | 201 |
| 17:14:55 | 37,335 | 134 |
| 17:12:59 | 37,355 | 597 |
| 17:12:00 | 37,470 | 123 |
| 17:11:47 | 37,450 | 200 |
| Tagesumsatz Xetra | +4,640 +14,11 % | 41.498 |
Angaben in grüner Schrift zeigen, dass der Aktienkurs im Vergleich zum vorherigen Kurs gestiegen ist. Angaben in roter Schrift zeigen gefallene Börsenkurse.
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| MODERNA Aktie jetzt für 0€ handeln | |||||
| 18:54 | Moderna outlines up to 10% revenue growth for 2026 amid international expansion and cost discipline | 8 | Seeking Alpha | ||
| 18:51 | Biontech-Rivale Moderna wendet sich von US-Markt ab | 33 | manager-magazin.de | ||
| 18:46 | Moderna shares jump as company affirms growth outlook | 2 | BioPharma Dive | ||
| 18:10 | With the FDA's Moderna decision, vaccine makers face increasingly uncertain regulatory environment | 8 | FiercePharma | ||
| 17:26 | Moderna R&D spend shrunk 31% in 2025 amid major pipeline reorg | 5 | FierceBiotech |
1 2 3 4 5 Weiter >>
436 Nachrichten in den letzten 12 Monaten
| Zeit | Aktuelle Nachrichten | Medien | ||
|---|---|---|---|---|
| 13:06 | Medicenna Therapeutics Corp.: Medicenna Announces Changes to Board Composition | GlobeNewswire (Europe) | TORONTO and HOUSTON, Feb. 13, 2026 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. ("Medicenna" or the "Company") (TSX: MDNA, OTCQB: MDNAF), a clinical-stage immunotherapy company focused on the... ► Artikel lesen | |
| Do | CRISPR Therapeutics AG: CRISPR Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results | GlobeNewswire (Europe) | ZUG, Switzerland and BOSTON, Feb. 12, 2026 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP) today reported financial results for the fourth quarter and full year ended December 31, 2025. "As... ► Artikel lesen | |
| 17:48 | Valneva Provides Update on Recommendations for Use of IXCHIQ in the United Kingdom | GlobeNewswire (Europe) | Lyon (France), February 13, 2026 - Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that following a review of the benefits and risks of the Company's... ► Artikel lesen | |
| 14:12 | Medicenna Therapeutics Corp.: Medicenna Therapeutics Reports Third Quarter Fiscal 2026 Financial Results and Provides a Corporate Update | GlobeNewswire (Europe) | Medicenna to present updated internal and external data sets related to bizaxofusp (MDNA55) at the 7th Annual Glioblastoma Development Summit to be held in Boston from 17-19 February 2026 Updated... ► Artikel lesen | |
| 12:33 | EQS-News: Immunic AG: Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company | EQS Group (EN) | Issuer: Immunic AG
/ Key word(s): Financing
Immunic Announces Oversubscribed Private Placement of up to USD 400 Million to Accelerate Transformation into Commercial-Stage Company... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu MODERNA INC finden Sie auf Wallstreet Online.